"What do you like better? East Coast rap or HIV turning into full-blown AIDS?" the interviewer asks.
The accused stock swindler who famously jacked up the price of a lifesaving drug 5,000 percent will finally face a judge, on the very day LGBT people celebrate marriage equality.
The pharma CEO who proudly jacked up prices on HIV meds faces a new charge.
Derided for raising the price of a medication used by some with HIV, the former drug executive refused to answer questions and later insulted the committee.
The derided executive, arrested Thursday on securities fraud charges, resigns from his position.
The pharma CEO, now hit with securities fraud charges, is a potent symbol of corporate greed. Now we need to learn from Shkreli's bad example and reform his industry, writes Kit Williamson.